Introduction
Chronic kidney disease is a real public health problem [1] . Hemodialysis patients are faced with the risk of cardiovascular diseases which are the first cause of mortality among this population. Cardiovascular diseases' index varies from 25% to 60% among patients with chronic renal disease [2] . These cardiovascular diseases claim 44% of deaths among hemodialysis patients [3] . The risk of hemodialysis patients' death is 5 to 20 times higher compared to the general population [4] .
Metabolic syndrome is an entity that brings together in the same individual, several metabolic abnormalities which predispose him to cardiovascular risks. Metabolic syndrome is itself one of the main risk factors for cardiovascular diseases [5] .
The prevalence of metabolic syndrome among the general population is 13.3% in China in 2006 [6] , 22% in the United States in 2012 [5] . Jalalzadeh observed among hemodialysis patients in Iran in 2011, 28.7% prevalence; Pérez in Spain in 2014, 29% and Maoujoud in Morocco recorded in 2011, 44% [7] [8] [9] . This prevalence within hemodialysis population may reach 70% [10] . Metabolic syndrome triples the risk of developing cardiovascular disease [9] [11], and increases two-fold mortality among hemodialysis patients [12] .
In Benin, the prevalence of the metabolic syndrome among chronic hemodialysis patients is unknown. The factors associated with metabolic syndrome among these patients have not yet been identified. This justifies the interest in this study on the metabolic syndrome among hemodialysis patients at the National Teaching Hospital Hubert Koutoukou Maga (CNHU-HKM) of Cotonou.
Objectives

General Objective
• Study metabolic syndrome among hemodialysis patients monitored in CNHU-HKM.
Specific Objectives
• Determine metabolic syndrome prevalence among patients undergoing hemodialysis.
• Identify factors associated with metabolic syndrome among hemodialysis patients. Metabolic syndrome occurs with a patient if his/her waist size is high and associated with at least two other criteria [13] .
Patients and Methods
The waist circumference was measured at the end of hemodialysis session, in sitting position, with a measuring tape, placed in the middle of the distance between the iliac crest and the lower costal margin, on the narrowest abdominal section.
Other variables sought were socio-demographic data (age, gender, profession, marital status); medical history (diabetes, hypertension); lifestyle (alcohol abuse, and level of physical activity), dialysis parameters (usual number of hours of dialysis per session, frequency of dialysis per week, type of arterio-venous fistula or catheter, duration under hemodialysis, percentage of urea reduction) and biological data.
Patients practicing less than 30 minutes of physical activity per day were considered as inactive. Otherwise, they were considered active. Anemia is defined by a rate of hemoglobin below 10 g/dl according kidney Disease Improving Global Outcome (KDIGO) guideline [14] . Urea reduction percentage (URP) was calculated on the ratio of the difference between blood urea nitrogen before dialysis and the one after dialysis on blood urea nitrogen before dialysis multiplied by 100. The URP is considered as normal when it is above or equal to 60%. With regard to biological data, blood sampling was made for each patient at the beginning of one of the he-modialysis sessions in the morning. Associated factors were sought by using logistic regression in univariate analysis. Data entry and analysis were performed using Epi Data 3.1. P-value below 0.05 was considered significant.
Results
General Characteristics of the Population
The study population comprised 165 hemodialysis patients. Male predominance was noted with 1.27 sex-ratio. Average age was 49.3 ± 12.9 years with extremes ranging from 18 to 78 years. Hypertension (HTA) was observed among 103 patients (62.4%). Arteriovenous fistula (AVF) was the privileged vascular access, and it was observed among 140 patients (84.8%). Average BMI of patients was 22.5 ± 6.8 kg/m² with extremes ranging from 14.5 to 62.14 kg/m 2 . Table 1 shows the general characteristics of hemodialysis patients.
Metabolic Syndrome Prevalence
Metabolic syndrome was observed among 46 hemodialysis patients or 27.9% preva- Table 2 shows metabolic syndrome prevalence and metabolic syndrome criteria among hemodialysis patients.
Factors Associated with Metabolic Syndrome
Factors associated with metabolic syndrome in univariate analysis were gender (p < 0.001), age (p = 0.007), body mass index (p = 0.029), and diabetes history (p = 0.011). Table 3 shows factors associated with metabolic syndrome among hemodialysis patients in univariate analysis.
Discussion
Metabolic Syndrome Prevalence
In this study, the definition of metabolic syndrome is based on IDF criterion, which is a reliable definition of metabolic syndrome. It is the most used and practical in the sense that the excess abdominal fat estimated through waist size is considered as a vital criterion [13] .
Metabolic syndrome prevalence among hemodialysis patients was 27.9% in Spain and Russia while similar results were reported by Perez and Radojica [8] [15] . In their studies, metabolic syndrome prevalence was respectively 29% and 29.8% in hemodialysis patients [8] and 34.3% [11] [16] . In UCAR study, metabolic syndrome prevalence based on IDF criteria was 36% [17] . Higher metabolic syndrome prevalence among hemodialysis patients 52% was reported by Chang et al. [5] . In that study metabolic syndrome was de- 
Factors Associated with Metabolic Syndrome
Gender was associated with metabolic syndrome, and female subjects were 2. 
Conclusion
Metabolic syndrome is common among hemodialysis patients. Early screening and fighting against the risk factors are necessary. It is important to introduce a dietician in these hemodialysis patients' support team in order to prevent cardiovascular complica-tions.
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